21.11.2013 Views

View PDF Version - RePub - Erasmus Universiteit Rotterdam

View PDF Version - RePub - Erasmus Universiteit Rotterdam

View PDF Version - RePub - Erasmus Universiteit Rotterdam

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Genetic analysis<br />

Fresh tumor tissue obtained from patient D at neurosurgery was used for DNA extraction<br />

and interphase cytogenetic analysis. DNA extraction, Southern blotting and hybridization<br />

were performed according 10 standard procedures. The following polymorphic DNA markers<br />

for loci on chromosome 22 were used: D22S181, D22S183, D22SIO, D22S182, D22SI,<br />

D22S 193, cos 50BII. The probes are ordered from centromere to telomere (van Biezen et<br />

aI., 1993).<br />

INTERPHASE CYTOGENETICS. Nuclei isolated from freshly removed tumor cells, were<br />

investigated for aberrations of chromosomes #1, 6, 7, 10, 11, 17, 18, 22, X and Y by<br />

fluorescent in situ hybridisation (FISH), according to Arnoldus et al (1990). In addition, we<br />

used probes specific for the centromeric regions of chromosome 22 (p22!1 :2.1), and two<br />

cosmid probes (cos 58BI2 & cos 50BII) that are located close to D22S193 on band 22qll.<br />

One hundred cells were counted for each probe. Cultured lymphocytes from blood of an<br />

unrelated subject were used as control.<br />

Results<br />

Cytogenetic analysis of respectively lymphocytes and fibroblasts in patients C and D showed<br />

a normal male karyotype. The tumor of patient D was investigated in more detail. Interphase<br />

cytogenetic analysis performed on freshly removed tumor tissue with probes for chromosome<br />

#1,6,7,10,11, IS, 17, 18,X and Y revealed results in the normal range. This indicates a diploid<br />

tumor, without gross chromosomal aberrations of these chromosomes.<br />

Additional techniques were applied to investigate chromosome 22. Interphase<br />

cytogenetics on freshly removed tumor tissue showed only one tluorescent spot in about 76%<br />

of nuclei, using 3 probes for chromosome 22 (table I). Moreover, 7 polymorphic probes for<br />

chromosome 22 were used to study possible loss of heterozygosity (LOH) in tumor DNA.<br />

D22S193 was the only informative probe. This probe clearly showed LOH when DNA<br />

derived from freshly removed tumor tissue was compared with DNA from fibroblasts of the<br />

same patient. In addition, we looked at mutations in the recently cloned NF2 gene, using<br />

RNA SSCP analysis. No evidence for mutations was observed in RNA from this tumor.<br />

However, the same method showed mutations in 36% of 53 meningiomas and schwannomas<br />

106

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!